1887

Abstract

Tuberculosis (TB) meningitis is extremely difficult to diagnose due to its pauci-bacillary disease nature and new techniques are needed. Improved test sensitivity would allow for greater clinician confidence in diagnostic testing and has the potential to improve patient outcomes. Traditional microbiologic and molecular tests for TB meningitis focus on detection of TB bacilli and are inadequate. Smear microscopy is rapid but only ~10–15  % sensitive. Culture has 50–60  % sensitivity but is slow. Xpert MTB/Rif Ultra is a rapid, automated PCR-based assay with ~70  % sensitivity versus clinical case definition. Thus, even the best current testing may miss up to 30  % of cases. Clinicians are often left to treat empirically with prolonged regimens with significant side effects or risk a missed case that would result in death. Rather than relying strictly on microbiologic or molecular testing to diagnose TB meningitis, we propose that testing of CSF for biomarkers of host response may have an adjunctive role to play in improving the diagnosis of TB meningitis.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000975
2019-05-01
2019-12-07
Loading full text...

Full text loading...

References

  1. Bahr NC, Marais S, Caws M, van Crevel R, Wilkinson RJ et al. GeneXpert MTB/Rif to diagnose tuberculous meningitis: perhaps the first test but not the last. Clin Infect Dis 2016;62:1133–1135 [CrossRef]
    [Google Scholar]
  2. Bahr NC, Boulware DR. Methods of rapid diagnosis for the etiology of meningitis in adults. Biomark Med 2014;8:1085–1103 [CrossRef]
    [Google Scholar]
  3. Karstaedt AS, Valtchanova S, Barriere R, Crewe-Brown HH. Tuberculous meningitis in South African urban adults. QJM 1998;91:743–747 [CrossRef]
    [Google Scholar]
  4. Ahuja GK, Mohan KK, Prasad K, Behari M. Diagnostic criteria for tuberculous meningitis and their validation. Tuber Lung Dis 1994;75:149–152 [CrossRef]
    [Google Scholar]
  5. Thwaites GE, Chau TT, Stepniewska K, Phu NH, Chuong LV et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002;360:1287–1292 [CrossRef]
    [Google Scholar]
  6. Ssengooba W, Respeito D, Mambuque E, Blanco S, Bulo H et al. Do Xpert MTB/RIF cycle threshold values provide information about patient delays for tuberculosis diagnosis?. PLoS One 2016;11:e0162833 [CrossRef]
    [Google Scholar]
  7. Bahr NC, Nuwagira E, Evans EE, Cresswell FV, Bystrom PV et al. Diagnostic accuracy of Xpert MTB/RIF ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis 2018;18:68–75 [CrossRef]
    [Google Scholar]
  8. Bahr NC, Tugume L, Rajasingham R, Kiggundu R, Williams DA et al. Improved diagnostic sensitivity for tuberculous meningitis with Xpert(®) MTB/RIF of centrifuged CSF. Int J Tuberc Lung Dis 2015;19:1209–1215 [CrossRef]
    [Google Scholar]
  9. Deopujari CE, Padayachy L, Azmi A, Figaji A, Samantray SK. Neuroendoscopy for post-infective hydrocephalus in children. Childs Nerv Syst 2018;34:1905–1914 [CrossRef]
    [Google Scholar]
  10. Nhu NT, Heemskerk D, Thu do DA, Chau TT, Mai NT et al. Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis. J Clin Microbiol 2014;52:226–233 [CrossRef]
    [Google Scholar]
  11. Patel VB, Theron G, Lenders L, Matinyena B, Connolly C et al. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med 2013;10:e1001536 [CrossRef]
    [Google Scholar]
  12. Chaidir L, Annisa J, Dian S, Parwati I, Alisjahbana A et al. Microbiological diagnosis of adult tuberculous meningitis in a ten-year cohort in Indonesia. Diagn Microbiol Infect Dis 2018;91:42–46 [CrossRef]
    [Google Scholar]
  13. Marais S, Thwaites G, Schoeman JF, Török ME, Misra UK et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis 2010;10:803–812 [CrossRef]
    [Google Scholar]
  14. Modi M, Sharma K, Sharma M, Sharma A, Sharma N et al. Multitargeted loop-mediated isothermal amplification for rapid diagnosis of tuberculous meningitis. Int J Tuberc Lung Dis 2016;20:625–630 [CrossRef]
    [Google Scholar]
  15. Hernandez-Pando R, Orozco H, Arriaga K, Sampieri A, Larriva-Sahd J et al. Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis. Immunology 1997;90:607–617 [CrossRef]
    [Google Scholar]
  16. Li J, Shen J, Lao S, Li X, Liu J et al. Mycobacterium tuberculosis Rv3615c is a highly immunodominant antigen and specifically induces potent Th1-type immune responses in tuberculosis pleurisy. Clin Sci 2017;131:1859–1876 [CrossRef]
    [Google Scholar]
  17. van Laarhoven A, Dian S, Ruesen C, Hayati E, Damen MSMA et al. Clinical parameters, routine inflammatory markers, and LTA4H genotype as predictors of mortality among 608 patients with tuberculous meningitis in Indonesia. J Infect Dis 2017;215:1029–1039 [CrossRef]
    [Google Scholar]
  18. Thuong NTT, Heemskerk D, Tram TTB, Thao LTP, Ramakrishnan L et al. Leukotriene A4 hydrolase genotype and HIV infection influence intracerebral inflammation and survival from tuberculous meningitis. J Infect Dis 2017;215:1020–1028 [CrossRef]
    [Google Scholar]
  19. Croda MG, Vidal JE, Hernández AV, Dal Molin T, Gualberto FA et al. Tuberculous meningitis in HIV-infected patients in Brazil: clinical and laboratory characteristics and factors associated with mortality. Int J Infect Dis 2010;14:e586–e591 [CrossRef]
    [Google Scholar]
  20. Marais S, Pepper DJ, Schutz C, Wilkinson RJ, Meintjes G. Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting. PLoS One 2011;6:e20077 [CrossRef]
    [Google Scholar]
  21. van Crevel R, Karyadi E, Preyers F, Leenders M, Kullberg BJ et al. Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis 2000;181:1194–1197 [CrossRef]
    [Google Scholar]
  22. Rook GA. Th2 cytokines in susceptibility to tuberculosis. Curr Mol Med 2007;7:327–337 [CrossRef]
    [Google Scholar]
  23. Heitmann L, Abad Dar M, Schreiber T, Erdmann H, Behrends J et al. The IL-13/IL-4Rα axis is involved in tuberculosis-associated pathology. J Pathol 2014;234:338–350 [CrossRef]
    [Google Scholar]
  24. Mastroianni CM, Paoletti F, Lichtner M, D'Agostino C, Vullo V et al. Cerebrospinal fluid cytokines in patients with tuberculous meningitis. Clin Immunol Immunopathol 1997;84:171–176 [CrossRef]
    [Google Scholar]
  25. Thwaites GE, Chau TT, Farrar JJ. Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol 2004;42:378–379 [CrossRef]
    [Google Scholar]
  26. Porcel JM. Tuberculous pleural effusion. Lung 2009;187:263–270 [CrossRef]
    [Google Scholar]
  27. Xu HB, Jiang RH, Li L, Sha W, Xiao HP. Diagnostic value of adenosine deaminase in cerebrospinal fluid for tuberculous meningitis: a meta-analysis. Int J Tuberc Lung Dis 2010;14:1382–1387
    [Google Scholar]
  28. Corral I, Quereda C, Navas E, Martín-Dávila P, Pérez-Elías MJ et al. Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients: limited value for diagnosis of tuberculous meningitis. Eur J Clin Microbiol Infect Dis 2004;23:471–476 [CrossRef]
    [Google Scholar]
  29. Yu J, Wang ZJ, Chen LH, Li HH. Diagnostic accuracy of interferon-gamma release assays for tuberculous meningitis: a meta-analysis. Int J Tuberc Lung Dis 2016;20:494–499 [CrossRef]
    [Google Scholar]
  30. Huang TY, Zhang XX, Wu QL, Peng WG, Zheng GL et al. Antibody detection tests for early diagnosis in tuberculous meningitis. Int J Infect Dis 2016;48:64–69 [CrossRef]
    [Google Scholar]
  31. Lu D, Chen C, Yu S, Chen S. Diagnosis of tuberculous meningitis using a combination of peripheral blood T-SPOT.TB and cerebrospinal fluid interferon-γ detection methods. Lab Med 2016;47:6–12 [CrossRef]
    [Google Scholar]
  32. Juan RS, Sánchez-Suárez C, Rebollo MJ, Folgueira D, Palenque E et al. Interferon gamma quantification in cerebrospinal fluid compared with PCR for the diagnosis of tuberculous meningitis. J Neurol 2006;253:1323–1330 [CrossRef]
    [Google Scholar]
  33. Luca MC, Petrovici C-M, Vâţă A, Dorobăţ C, Năstase E et al. [Gamma interferon testing in blood and cerebrospinal fluid–rapid method for the diagnosis of tuberculous meningitis]. Rev Med Chir Soc Med Nat Iasi 2008;112:108–110
    [Google Scholar]
  34. Thwaites GE. Advances in the diagnosis and treatment of tuberculous meningitis. Curr Opin Neurol 2013;26:295–300 [CrossRef]
    [Google Scholar]
  35. Patel VB, Singh R, Connolly C, Coovadia Y, Peer AK et al. Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population. Am J Respir Crit Care Med 2010;182:569–577 [CrossRef]
    [Google Scholar]
  36. World Health Organization Commercial serodiagnostic tests for diagnosis of tuberculosis: expert group Meeting report, 22 July 2010 Geneva: World Health Organization; 2011
  37. Vita S, Ajassa C, Caraffa E, Lichtner M, Mascia C et al. Immunological diagnosis as an adjunctive tool for an early diagnosis of tuberculous meningitis of an immune competent child in a low tuberculosis endemic country: a case report. BMC Res Notes 2017;10:123 [CrossRef]
    [Google Scholar]
  38. Achkar JM, Cortes L, Croteau P, Yanofsky C, Mentinova M et al. Host protein biomarkers identify active tuberculosis in HIV uninfected and Co-infected individuals. EBioMedicine 2015;2:1160–1168 [CrossRef]
    [Google Scholar]
  39. Wheat LJ, Azar MM, Bahr NC, Spec A, Relich RF et al. Histoplasmosis. Infect Dis Clin North Am 2016;30:207–227 [CrossRef]
    [Google Scholar]
  40. Walsh TJ, Raad I, Patterson TF, Chandrasekar P, Donowitz GR et al. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis 2007;44:2–12 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000975
Loading
/content/journal/jmm/10.1099/jmm.0.000975
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error